P21 Pathway

The p21 Pathway is a molecular signaling cascade, within the broader class of cell cycle regulatory pathways, that is distinguished by its activation of the cyclin-dependent kinase inhibitor p21 (CDKN1A) in response to DNA damage or stress signals, leading to cell cycle arrest and playing a central role in the establishment of cellular senescence, particularly in the context of radiation-induced senescence.

1.9K

Publications

129.4K

Citations

10.7K

Authors

2K

Institutions

Publications per year

2017–2026

404

Variants

Cdkn1a PathwayP21 Signaling Pathway

Authors

10.7K

  1. YH
    Yung Hyun Choi

    Dong-Eui University, South Korea

    11 publications · 790 citations

    11

    h-index

  2. MG
    Myriam Gorospe

    National Institute on Aging, United States

    10 publications · 1.5K citations

    10

    h-index

  3. RH
    Robert H. Weiss

    University of California, Davis, United States

    8 publications · 537 citations

    8

    h-index

  4. JC
    Jonathan Chernoff

    Fox Chase Cancer Center, United States

    8 publications · 913 citations

    8

    h-index

  5. SA
    Stuart A. Aaronson

    National Cancer Institute, United States

    7 publications · 892 citations

    7

    h-index

1–5 of 10.7K

Venues

  1. Oncogene

    126 publications · 9.7K citations

    59

    h-index

  2. Journal of Biological Chemistry

    JBC · 83 publications · 8K citations

    53

    h-index

  3. PubMed

    Repository · 99 publications · 7.3K citations

    47

    h-index

  4. Biochemical and Biophysical Research Communications

    BBRC · 63 publications · 2.2K citations

    31

    h-index

  5. Cancer Letters

    40 publications · 1.7K citations

    26

    h-index

1–5